Iovance Biotherapeutics IOVA Cash Flow Statement (2010-2026)

NASDAQ IOVA
$8.79 +0.09 (+1.03%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Iovance Biotherapeutics Quarterly Cash Flow Statement

Periods 59 quarters
Latest Jun 2026

Iovance Biotherapeutics reported cash from operations of -$60.81M and free cash flow of -$66.26M for the quarter ended Jun 2026, up 9.8% year over year. This cash flow statement covers 59 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Dec2013 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-86.12M-99.33M-93.45M-99.35M-99.62M-105.32M-107.37M-106.50M-113.76M-116.36M-112.98M-97.06M-83.54M-78.57M-116.16M-111.67M-91.25M8.52M-79.01M-47.29M
Share-based CompensationStock Comp.
17.00M19.10M22.27M14.52M14.86M19.51M19.26M19.44M19.27M14.40M17.18M18.88M31.01M30.98M22.91M18.99M18.61M-49.16M17.71M17.57M
Deferred Taxes
-0.48M-1.24M-1.76M-1.41M-1.46M-1.52M1.56M-1.84M1.99M-2.40M0.18M-0.67M-1.37M
Asset Writedowns and ImpairmentWritedown
0.31M0.08M7.36M-0.01M8.32M1.39M3.70M-0.51M3.31M
Cash from OperationsCash from Ops.
-57.69M-53.85M-73.80M-77.64M-63.65M-77.67M-99.81M-93.95M-84.08M-83.97M-122.28M-98.43M-58.97M-73.30M-103.69M-67.45M-78.70M-52.56M-72.10M-60.81M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
2.94M3.12M3.18M3.00M2.75M2.89M2.93M2.98M2.94M2.85M2.33M2.50M2.65M2.95M2.87M2.88M2.92M2.72M1.88M0.90M
Depreciation & Amortization (CF)Dep. & Amort.
1.03M1.34M1.80M2.20M2.50M2.81M2.80M2.90M2.90M2.95M3.00M3.00M3.00M3.27M2.57M3.40M3.19M3.72M2.82M3.78M
Change in Working Capital
Change in ReceivablesChange Receivables
0.03M-0.03M0.15M0.08M31.37M24.16M13.57M1.60M-11.00M6.82M15.69M-0.69M20.36M
Change in InventoryChange Inventory
9.55M-0.35M0.92M6.74M8.86M9.86M18.93M13.83M-6.65M3.02M4.00M4.93M0.18M
Change in Account PayablesChange Payables
-5.69M7.72M-2.10M2.17M4.26M1.56M3.02M0.15M-9.77M11.42M-5.82M-10.39M14.44M-6.07M2.05M0.89M-4.39M-5.21M15.89M-11.82M
Change in Accured ExpensesChange Accured Exp.
8.48M11.60M-5.16M-9.89M9.44M0.91M-9.05M3.49M15.93M9.40M-23.02M14.81M12.70M4.08M2.25M-0.28M5.50M21.17M-21.04M-8.62M
Investing Activities
Capital ExpendituresCapex
9.69M7.57M11.44M4.58M1.39M3.02M7.78M7.41M3.58M3.53M4.17M0.44M2.29M4.17M6.21M7.46M10.84M9.32M6.61M5.44M
Acquisitions
3.38M-0.25M
Change in Acquisitions & DivestmentsChange Acquisitions
224.30M218.46M143.51M140.63M139.45M99.11M164.38M62.25M20.95M38.00M87.00M115.00M110.00M116.00M120.00M90.00M120.00M70.00M74.00M61.00M
Cash from Investing ActivitiesCash from Investing
12.75M69.34M86.52M95.76M73.72M0.46M153.40M-156.78M-79.01M-72.84M-111.51M40.22M-48.80M23.68M15.87M13.84M17.01M0.78M11.39M-74.05M
Financing Activities
Other financing activitiesOther financing
19.80M3.53M1.42M-2.65M0.23M0.06M0.01M0.36M0.39M0.71M1.80M0.01M
Cash from Financing ActivitiesCash from Financing
20.77M4.15M1.42M-2.07M0.23M190.57M258.17M1.02M202.80M0.96M193.58M152.82M41.95M2.31M143.31M13.23M88.06M56.17M94.33M49.29M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
5.53M1.89M3.46M4.29M5.38M1.99M0.90M3.46M0.43M
Net Equity Issued and RepurchasedNet Equity Issued
0.00M189.50M260.10M41.70M0.00M197.91M151.87M47.52M148.94M13.10M88.52M55.78M98.51M49.60M
Additional items
Exchange Rate EffectFX Effect
-3.77M-1.99M3.02M-0.49M-0.12M1.25M-1.18M0.51M0.74M-0.68M0.58M-0.21M-0.12M
Change in Cash
-24.17M19.64M14.13M16.06M10.29M113.36M311.75M-253.47M37.71M-152.83M-40.70M94.49M-64.57M-48.49M56.00M-39.64M25.69M4.96M33.44M-85.73M
Free Cash FlowFCF
-67.38M-61.42M-85.24M-82.21M-65.04M-80.69M-107.59M-101.36M-87.66M-87.50M-126.45M-98.87M-61.26M-77.46M-109.91M-74.91M-89.55M-61.88M-78.71M-66.26M
Net Cash FlowNCF
-24.17M19.64M14.13M16.06M10.29M113.36M311.75M-249.71M39.70M-155.85M-40.21M94.61M-65.82M-47.31M55.49M-40.38M26.37M4.38M33.63M-85.58M